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1 Abstract 
1.1 Purpose 
The purpose of this study is to prescribe follicular-like conjunctivitis associated with Sili-
conhydrogels (FoCoSi) in silicone hydrogel contact lens wearers as a novel subtype of 
the well prescribed contact lens induced papillary conjunctivitis (CLPC). 
1.2 Methods 
1211 patients who wore silicon hydrogels were included in this prospective, non-
randomised, single center study. Subjective symptoms and clinical signs were evaluated 
for daily wear (DW) and continuous wear (CW) populations for several (Lotrafilcon A, 
Lotrafilcon B, Senofilcon A, Galyfilcon A) silicon hydrogel lens types. CCLRU and other 
specifically developed grading scale were utilized for evaluation. Grading of 2 and above 
was rated as clinically significant. Statistical evaluation was performed for eyes rather 
than subjects. 
1.3 Results 
The clinical presentation of FoCoSi could be confirmed and showed an incidence of 
3.8%. Lotrafilcon A followed by Senofilcon A on a CW modality presented, with a risk 
ratio of 2.49 and 1.53 respectively, the highest affinity for developing FoCoSi. Fluo-
rescein positive spots showed the closest correlation with subjective symptoms reported 
by patients and divided FoCoSi into an active and dormant form. Besides Protein, Lipid 
deposition on the contact lens surface and air pollution like Ozone or fine and ultrafine 
particles seems to be important factors in developing FoCoSi, whereas mechanical irri-
tation played a minor role. 
1.4 Conclusion 
FoCoSi is a novel and relevant subtype of CLPC. Further studies should be performed 
to validate these findings and clear up several questions about the aetiology of FoCoSi 
and CLPC. 
 
Keywords: Giant papillary conjunctivitis (GPC), contact lens-induced papillary conjuncti-
vitis (CLPC), follicular-like conjunctivitis associated with siliconhydrogels (FoCoSi) 
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2 Introduction CLPC 
Contact lens-induced papillary conjunctivitis (CLPC), also known as giant papillary con-
junctivitis (GPC), is a well prescribed condition and a major cause of permanently dis-
continuation of contact lens wear.1 It is an inflammatory and usually reversible condition 
that is characterized by enlarged papillae, hyperaemia of the palpebral conjunctiva and 
excessive mucus discharge. Symptoms include discomfort, pruritus or itching, foreign 
body sensation, excessive movement, decentration and deposits on the contact lens, 
resulting in blurred vision and decreased visual acuity.2,3,4,5,6 The condition was first re-
ported in 1970 in a patient wearing rigid contact lenses5 and later by Spring7 in 1974 in 
patients wearing hydrophilic contact lenses and has since been frequently reported in 
wearers of both rigid and soft contact lenses.3,4,5,8,9,10,11,12 The incidence of CLPC varies 
but is greatest with soft contact lens wear (from 1.9% to 45%)13,14,15,16,17,18 especially while 
wearing conventional soft contact lenses extended wear (EW).2,15,19  Disposable soft con-
tact lenses, especially if wearing time is under 3 weeks, showed significant lower inci-
dence of CLPC than conventional soft lenses.13,14,19 No CLPC at all was found in patients 
wearing their contact lenses on a 1 week or 1 day replacement cycle.20 Preliminary stud-
ies and case reports by Stern18 and Skotnitsky21 suggest that there is a greater occur-
rence of CLPC with silicone hydrogel (SH) lenses. When comparing six nights of ex-
tended wear to 30 nights of extended wear with SH, there was no difference in the oc-
currence of CLPC.18 
2.1 Aetiology 
Papillae are small protuberances with nerve endings that respond to stimulation. A vas-
cular supply is observed radiating from a vessel occupying the central fibrotic core of 
each papilla.22,23,24,86 The conjunctival epithelium overlying the giant papillae is thickened 
and irregular, with many invaginations into the stroma. Excised papillae consist of con-
junctival epithelial cells, goblet cells, mucus granules in non-goblet epithelial cells, in-
flammatory leucocytes including mast cells, plasma cells, lymphocytes, eosinophils, ba-
sophils and neutrophils in the epithelium, basophils in the substantia propria and newly 
formed vessels among excessive fibrosis.3,25,26,27,28,29,30,31,32,86 Recent immunohistochemical 
studies have demonstrated an increase in the number of CD4+ T cells, memory T cells, 
eotaxine and cytokine production in GPC specimens compared with normal tis-
sue.33,34,35,36 Sulfidopeptide leukotriens produce increased microvascular permeability in a 
variety of tissues, which results in edema formation due to the extravascular accumula-
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tion of plasma. Leukotriens (LT) are found in a higher concentration in patient with 
CLPC and in patients with allergies and LT acts independently of histamine.86 Immu-
noglobulin (IgE and IgG) antibodies in the tears and degranulated mast cells in ocular 
tissue were increased in patients with CLPC.37,38,39 All those results indicate that it is an 
Immunoglobulin mediated type 1 hypersensitivity reaction.  
The papillae extend from the upper palpebral conjunctiva and appear as round light re-
flexes giving an irregular specular reflection. The number of papillae can vary from hun-
dreds covering the entire tarsal conjunctiva to one papilla.22,39 The term GPC has been 
used to describe inflammation of the tarsal conjunctiva as has been reported with ex-
posed sutures, ocular prosthesis, extruded scleral buckles, cyanoacrylate adhesive, and 
epithelization of corneal bodies.29,40,41,42,43,44,45 The response of the tarsal conjunctiva to a 
raised foreign object suggests mechanical trauma may play a role in the aetiology of this 
condition. In these cases, enlarged papillae are found localized to the area of the tarsal 
conjunctiva that is in contact with the stimuli.  
2.1.1 GPC compared with vernal keratoconjunctivitis 
The term “giant” was coined for the large papillae crowded together to reach a diameter 
of 1.0 mm or more and is similar to that produced by vernal keratoconjunctivitis (VKC).37 
VKC and GPC develop similar symptoms and clinical signs and are thought to belong to 
the same clinical spectrum. Pathologic findings of giant papillary proliferation in VKC are 
characterized by infiltration of inflammatory cells and proliferation of connective tissues 
in subconjunctival tissue. In the conjunctival epithelium of VKC patients, infiltration of 
inflammatory cells such as mast cells and basophils is observed. Infiltration of eosino-
phils,46,47 helper T cells type 2 (Th2),48,49 and CD45RO-positive lymphocytes50 are also 
observed in the subconjunctival tissue. These findings are compatible with a tissue reac-
tion caused by allergic inflammation. It has been reported that various substances, such 
as chymase produced by mast cells,51 Th2 cytokines produced by Th2 lymphocytes, 
interleukin (IL)-4 and IL-5,52 eotaxin, which promotes the infiltration of eosinophils,53 and 
eosinophil cationic protein, which is one of the eosinophil specific granule proteins, in-
crease in the tears of patients with VKC.54 Although the histological abnormalities of 
mast cells, eosinophlis and basophils are present in both conditions, they are present to 
a much higher degree in VKC than in GPC. Especially the numbers of Eosinophils and 
percentage of degranulated Mastcells are significantly elevated in VKC, compare to 
GPC.26,27 
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2.1.2 Contact lens induced papillary conjunctivitis 
A more appropriate term that covers the condition of enlarged papillae with contact lens 
wear is contact lens induced papillary conjunctivitis (CLPC).55 It can occur bilaterally or in 
10% of cases truly unilaterally.17 Epidemiological studies demonstrated that the presen-
tation of CLPC in hydrogel contact lens wearers has a mean onset time between 4.3 
and 31 months after commencing contact lens wear.11,16,38 Gender was not found to be a 
relevant associated factor for CLPC.11 Patients with a history of allergy have been re-
ported to be more susceptible to CLPC.20,56,57 Of further significants is the distribution in 
time of diagnosis of CLPC, with peaks in spring and in late summer to early fall, which 
was assumed to correlate with ragweed pollen season.58 There have been reports pre-
scribing differences in the distribution of papillae across the tarsal conjunctiva with dif-
ferent contact lens types.39,59,60 In Korb’s et al 39,56 studies, papillae in soft lens wearers 
developed first in zone 1 (area closest to the tarsal plate) and the remaining zones (the 
central tarsal conjunctiva and the region near the lid margin) became involved only after 
papillae developed in zone 1. In contrast, papillae in hard lens wearers were never ob-
served alone in zone 1 but did occur alone in zones 2 or 3. EW Studies with SH have 
indicated that there are two distinct categories of CLPC: general and local.16,21 CLPC 
involving enlarged papillae across the entire palpebral conjunctiva is classified as gen-
eral, and papillae confined to one or two areas, generally in the central region nearest 
the lid margin, are termed local. Patients with general CLPC typically experience more 
serious clinical symptoms and have more lens deposits than patients with local CLPC 
do. The location and limit of the affected area in local CLPC may indicate that local me-
chanical stimulation is the major cause of this condition, whereas general CLPC, in 
which the part of the palpebral conjunctiva not directly contacted by contact lenses is 
also affected, may indicate a general immunological hypersensitivity reaction.21  
The second most prevalent sign of CLPC, after the inflammation of the conjunctiva, is 
excessive mucus. There is no increasing of the number of mucus secreting goblet 
cells,61 moreover the mucus vesicles in non-goblet epithelial cells contribute dramatically 
to the increase of mucus production.62,63 Excess mucus in the tear film interfere with vi-
sion by coating contact lens surface and increased contact lens movement. Patients 
may report accumulation of mucus in nasal corner of the eye, especially upon awaken-
ing.58 
CLPC is thought to be an immunologic response to deposits (lipid, protein and 
mucin64,65) on the contact lens surface.55,66  Studies have provided valuable information 
about deposit composition and formation mechanisms. Tear protein identified include 
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lysozym, lactoferrin, protein-G, pre-albumin, albumin and immunoglobulines.67,68,69 Pro-
tein deposition varies in amount and activity and is driven primarly by contact lens poly-
mer composition, water content, pore size and mainly ionic nature. Lysozyme is mainly 
deposited on negatively charged substrates, whereas albumin is deposited on neutral 
and or positively charged materials. Higher water content contact lenses graded from 
the U.S. Food and Drug Administration (FDA) group II and IV have a tendency to have 
more deposits than lower water content lenses. Ionically charged contact lens polymers 
(FDA group III and IV) tend to attract proteins, such as lysozyme. Contact lenses of FDA 
group IV tend to have the greatest deposition of protein. Whereas protein is taken into 
the aqueous phase, lipid becomes associated with the polymer matrix itself, independ-
ent on material ionicity. Interestingly the protein deposition is largely unrelated to subjec-
tive differences, whereas lipid deposition is related to both material composition and in-
tersubject differences in tear film components, blink factors and environmental fac-
tors.64,70,71,72,73 SH materials have different deposition profiles to that seen with conven-
tional hydrogel lenses. The surfaces of SH materials are characteristically hydrophobic, 
typically significantly lower quantities of protein and higher levels of lipid deposition be-
ing measured.74,75,76,77,78 In Vitro Study79 and in Vivo study72 found the highest amount of 
Lipid adsorption (non-polar Cholesterol and polar phosphatidylethanolamine) in SH with 
senofilcon A, followed by galyfilcon A, (FDA group I), and balafilcon A (FDA group III), 
whereas the lowest adsorption was with lotrafilcon A and B (FDA group I). However, 
lipids alone do not appear to be antigenic.80 On the other hand, interaction among de-
positing materials may play a role because it has been shown that lipid deposits on FDA 
group IV lenses may inhibit deposition of lysozyme.81 The kinetics of protein showed no 
differences in Lysozym accumulation between 5 different SH materials until 5 days of 
wearing time. But increases consistently after a longer period of wearing time, without 
reaching a plateau like the FDA group IV materials.82,Jones and co-workers 68,69 found 
approximately 50% denatured lysozyme on balafilcon A ex vivo lenses and 80% on 
lotrafilcon A ex vivo lenses. Galyfilcon A lenses denatured only about 25% of the ly-
sozyme in vitro but approximately 50% in vivo. This difference in denaturation suggests 
in vivo factors such as the presence of other tear components (for example lipid), lens 
surface drying during the interblink period, and shear forces during blinking may all con-
tribute to denaturation of surface proteins during in-eye wear. An other study has dem-
onstrated that protein denaturation may play an important role in the development of 
CLPC.53 This fact is of significant interest at this time, because CLPC being reported at 
higher levels with silicon-based lenses than with conventional lens materials.21  
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Other factors such as meibomian gland dysfunction (MGD)17,83 have also been sug-
gested to be involved in the cause of CLPC. In contrast, the second study on that topic 
from Molinary et al 84 couldn’t find any correlations between MGD and CLPC anymore. 
Pollen and other allergenic substances adhere to the surface of the contact lens too, 
especially in patients with a poor tear film and poor contact lens wetting.24 Additionally 
the coated contact lens induces physical trauma to the conjunctival epithelium resulting 
in the release of chemotactic factors, such as neutrophilic chemotactic factor (NCF), 
causing the influx of various inflammatory cells.17,61,85 In CLPC patients NCF was in-
creased 15 times the level of asymptomatic patients. Biochemical characterization of the 
conjunctival factors showed that NCF are proteins of high molecular weights and are 
capable of producing a GPC-like inflammatory reaction in the upper tarsal of rabbits 
when they are injected daily for 7 days.82 Further more, the eventual activation of Li-
poxygenase results in the release of LK too.86  
After all, there has been no correlation between CLPC with a particular contact lens type 
or specific deposits so far. There have been no studies that have shown a biochemical 
or morphologic difference between the coating on contact lenses from patients with and 
without CLPC. Ballow et al.63 have shown that when contact lenses from patients with 
CLPC are placed on monkey eyes, a papillary tarsal reaction develops with more of IgE 
and IgG. However, if contact lenses from asymptomatic patients (but have coated con-
tact lenses) are placed on the eyes of monkeys, a papillary reaction does not occur, nor 
is there an increase of tear immunoglobulins. 
In summary, the origin of CLPC appears to be a combination of mechanical irritation and 
immunological hypersensitivity reaction.58 
2.2 Purpose of this study 
Papillae consist of a vascular supply which is observed radiating from a vessel occupy-
ing the central core of each papilla.22,23,24,58 In contrast, as a differential diagnosis, follicle 
has a white center obscuring underlying vessels.22 (Figure 1) In vivo confocal micros-
copy showed in follicular conjunctivitis, a hyporeflective core containing hyporeflective 
round cells surrounded by a hyperreflective capsule and vessels.87 So follicles appear as 
round to oval elevations which measuring between 0.5 to 1.5 mm in diameter with a 
grey-white center. They can be seen in the inferior and superior tarsal conjunctiva, and 
less often, on bulbar or limbal conjunctiva. Patients may complain of ocular itching, for-
eign body sensation, tearing, redness, and photophobia.  
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Typical signs of viral conjunctivitis include preauricular adenopathy, epiphora, hypere-
mia, chemosis, subconjunctival haemorrhage, follicular conjunctival reaction and occa-
sionally a pseudo membranous or cicatricial conjunctival reaction. 88,89,90,91,92,93,94 The dis-
ease typically begins in one eye and progresses to the fellow eye over a few days. The 
second eye is usually less significantly involved.95,96 Presumed diagnosis with clinical 
findings, especially follicles, scanty watery discharge and preauricular adenopathy were 
consistent with laboratory findings in 76%.91  
 
Figure 1: Papilla versus Follicle (GOH Naumann Pathologie des Auges 1980;12:252) 
Viral conjunctivitis is typically characterized by a mononuclear cellular response with 
preponderance of lymphocytes or monocytes. In early stages neutrophils can be nu-
merous.92 Interestingly there is a seasonal variation in the aetiology of acute adenoviral 
conjunctivitis, reaching the peak in summer, followed by winter and spring, whereas 
Herpes simplex infections showed no seasonal peaks.89,97 The reason for these differ-
ences remain unclear in the studies. The cornea shows 3 to 4 days after onset of the 
symptoms a diffuse epithelial keratitis, followed, at 1 week, by a focal epithelial keratitis 
that persists for up to 2 weeks. Around this time, subepithelial infiltrates may be noticed 
beneath the focal epithelial lesions. They exhibit a round or nummular shape, may per-
sist for months or years,98 and represent an immune response to adenoviral antigens 
deposited in the corneal stroma. 
Follicles are most seen in viral (Adenovirus and Herpes simplex virus) or chlamydial in-
fections 89,90,93,94 but were never prescribed so far as a finding in CLPC. Despite there is 
few literature which prescribing a follicular-like response of the upper conjunctiva in 
CLPC 24,39,44,99 besides the response of papillae formation. This reaction was presumed in 
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severe cases with a longer period of time to be a cicatrisation of the conjunctiva surface 
at the apex of the papillae and appear in a cream/white colour.24,96 Sugar et al41 pre-
sumed a thickening of the overlaying conjunctiva as the reason for a milky appearance 
in some cases of GPC after keratoplasty. In earlier stages the papillae apex can display 
infiltrates, which appear in a whitish colour as well. Fluorescein staining occurs with 
epithelial cell damage and frequently occurs with papillae with apices that are flattened 
or crater-like.24,36,94 The reason for those alterations was presumed to be the initiating 
mechanical trauma. Greiner38 in contrast found no fluorescein staining over those whitish 
papillae in GPC due to an epithelialized foreign body. Despite the importance of differen-
tial diagnosis of contagious viral or chlamydial infection, risk factors and aetiology of this 
specific condition are not well understood. After introduction of Siliconhydrogel contact 
lenses we had a strong feeling of seeing more those whitish apices of papillae in pa-
tients with CLPC. The purpose of this study was to examine the distinct clinical presen-
tations of follicular-like conjunctivitis associated with Siliconhydrogels (FoCoSi) in cases 
with CLPC in a large number of Siliconhydrogel lens wearers. The study involved pro-
spectively collected data from subjects wearing their contact lenses on a regular modal-
ity and replacement schedule. The data was compared with an asymptomatic control 
group. 
3 Material and Methods 
The study was conducted from the kontaktlinsenstudio baertschi in Bern, Switzerland. A 
prospective, non randomised, single center study design was chosen for this research 
project. 1211 active silicone hydrogel contact lens wearers were included for the current 
analysis. Subjects with prior contact lens experience, as well as subjects with no prior 
contact lens wear experience (neophytes) were included. They had to have actively 
worn their lenses in their usual wearing mode, extended wear (EW) or daily wear (DW), 
in between the period of January 1st 2007 and December 31st 2007. All included sub-
jects had no history of ocular or systemic problems and no history of use of any medica-
tions that may affect contact lens wear.  
All four clinicians involved in clinical trials at the kontaktlinsenstudio baertschi underwent 
concordance training in ocular responses to ensure measurements were in close 
agreement. All experimental protocols are complied with the Declaration of Helsinki for 
Experimentation on Humans, 1975 and revised in 1983. 
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3.1 Demographic Statistics 
All subjects who wore silicon hydrogels in the period of the analysis were considered for 
the study. No exclusions due to age were made. Subjects ranged in age from 10 to 80 
years with a mean of 34.09 and 63% of them were female (Table 1 + 2).  
Age
6660544944393429241914
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40
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0
Age Table 1 
63%
37%
Female
Male
Gender Table 2 
3.2 Follow-up Schedule 
Every Patient was controlled at least two times, in a six month interval, during the study 
period. Neophytes for EW underwent a period of DW before beginning EW. During EW 
subjects were examined at 24hours, at one week and one month to assess the ocular 
response to EW. Thereafter subjects were seen at six month intervals for the duration of 
the study. If an additional adverse event happened, the patient was forced to come in for 
an unscheduled visit in the first three days after awareness of the event. As an adverse 
event were the following subjective symptoms defined: 
• Itchiness or scratchiness of one or both eyes (like feelings of an allergic reaction 
against Pollen) especially during evenings. These symptoms will be getting worth 
while rubbing or touching the eyes. 
• Increased production of mucus during wearing time of contact lenses. 
N 1211 
Mean Score 34.09 
Median 33 
SD +/-  10.242 
Minimum 10 
Maximum 80 
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• Decreased visual acuity and dislocation of contact lenses, due to enormous 
depositions on the surface of the contact lenses. 
3.3 Materials 
The contact lens materials included in the study were five different types of silicone hy-
drogel contact lenses: Lotrafilcon A, Lotrafilcon B, Balafilcon A, Galyfilcon A and Seno-
filcon A. The material properties can be viewed in Material100 Table 3. All possible varia-
tion, such as Toric or Multifocal Designs were included as well. 
Brand Name PureVision Night & Day 
Acuvue 
Advance 
Acuvue  
Oasys 
AirOptix 
Manufacturer 
Bausch & 
Lomb 
Ciba Vision Vistakon Vistakon Ciba Vision 
Material Balafilcon A Lotrafilcon A Galyfilcon A Senofilcon A Lotrafilcon B 
Dk 99 140 60 103 110 
Dk/t 110 175 86 147 138 
Center thickness 
(mm @ -3.00D) 0.09 0.08 0.07 0.08 0.08 
Water content 
(%) 36 24 47 38 33 
BC (mm) 8.6 8.4 / 8.6 8.3 / 8.7 8.4 / 8.8 8.6 
Refractive Index 1.426 1.43 1.41 1.42 1.42 
Surface Treat-
ment 
Plasma Oxida-
tion 
Plasma Coat-
ing 
Hydraclear 
Hydracelar 
plus 
Plasma Coat-
ing 
UV filter No No Yes Yes No 
FDA Group III I I I I 
Initial Modulus 
(MPa) 1.1 1.4 0.4 0.6 1.2 
Tensile Modulus 
(psl) 148 238 65 68 190 
Relative Initial 
Dehydration 
Rate 
1.9 1 2.4 1.8 1.5 
Material Table 3 
The distribution of the used contact lens materials can be seen in Table 4 and distribu-
tion is listed as follows: 29.9% of all subjects used Senoflicon A, Galyfilcon A Material 
was used by 29.7%, followed by Balafilcon A with 28%, Lotrafilcon A used 10.5% and 
finally Lotrafilcon B was used by 1.9%.  
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Contact lens material
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3.4 Methods 
First of all, visual acuity was noted as Visus (20/20 correlates to 1.0) according DIN / EN 
ISO normative data. (Table 5) 
Visus DIN / EN ISO Snellen 6m USA 
2.0 6/3 40/20 
1.6 6/3.75 32/20 
1.25 6/4.8 25/20 
1.0 6/6 20/20 
0.8 6/7.5 20/25 
0.63 6/10 20/32 
0.5 6/12 20/40 
0.4 6/15 20/50 
0.32 6/20 20/63 
0.25 6/24 20/80 
0.2 6/30 20/100 
0.16 6/38 20/125 
0.125 6/48 20/160 
0.1 6/60 20/200 
0.08  20/250 
0.063  20/317 
0.05  20/400 
Visus vs. Snellen Table 5  
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The cornea, bulbar conjunctiva, upper and lower tarsal conjunctiva were examined us-
ing the Bon Digipro 2 digital slit lamp biomicroscope with a resolutions of single pictures 
up to 1392 x 1040 Pixel and Videos up to 800 x 600 Pixel including a 5 step Galilean 
magnification changer (5x,10x,16x,25x,40x). Examination was made under both white 
light and cobalt blue light with a yellow fluorescein enhancement filter using a wide 
range of magnification levels. Fluorescein was used to detect corneal and conjunctival 
staining and to enhance the contrast in papillary size and definition. The subject re-
ported symptoms was graded as none (0), noticeable symptoms but without any limita-
tions in contact lens wear (1), slight annoying symptoms with slightly limitations in con-
tact lens wear (2), moderate symptoms and limitations in contact lens wear (3) and fi-
nally severe symptoms with severe limitations in contact lens wear (4). Subjects tearing 
at the moment of FoCoSi was graded as normal (0), pronounced tear meniscus (1), 
rarely overflowing tears (2), common overflowing tears (3) and excessive tearing or 
epiphora (4). Additionally, subjects preauricular lymph nodes were palpated and graded 
as no finding (0) or positive reaction (1) and furthermore the anterior portion of the eye 
was observed to rule out any probably associated virus infections. Finally subjects pre-
dominance to pollen allergy reaction was noted as no allergy history (0), reaction typi-
cally occurs in Spring (1), Summer (2), Spring and Summer (3) or 12 month atopic (4). 
3.4.1 Cornea 
The cornea was inspected and graded for 6 (Stromal edema, Microcysts/vacuols, Vas-
cularisation, fluorescein Staining, corneal Infiltrates and scarring of cornea) different 
hallmarks. Gradings above 2 were considered as clinical relevant. Stromal edema was 
graded as no striae (0), 1-5 striae (1), 6-20 striae with less than 5 folds and mild haze 
(2), more than 20 striae with more than 5 folds and moderate haze (3) and opacity from 
limbus to limbus (4). Microcysts/Vacuols were graded as none present (0), 1-10 present 
(1), 11-30 present (2), 31 – 70 present (3) and more than 70 microcysts/Vacuols (4). 
Vascularisation was graded as not visible (0), less than 1mm (1), between 1.0 to 1.5mm 
(2), between 1.6mm to 2.0mm (3) and more than 2.0mm (4). Additionally localisation of 
vascularistation was graded as superior (0), inferior (1), temporal (2), nasal (3) and cir-
cular (4). For fluorescein staining were 3 different gradings developed, distinguish the 
area, localisation and depth. In detail the gradings for area was no staining (0), 1-20 
punctate staining (1), 21-40 punctate staining (2), more than 41 punctate, diffuse region 
of staining (3) and dense areas with fluent areas. Staining localisation was graded as 
superior (0), inferior (1), temporal/nasal (2), central (3) and staining over the whole cor-
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nea (4). Finally depth was graded as no stroma diffusion (0), delayed diffusion of about 
30-60sec (1), delayed diffusion of about 5-29sec (2), immediate, slight diffusion (3) and 
immediate diffusion into a wide area of the stroma (4). Infiltrates were graded for 4 dif-
ferent category groups (appearance of Infiltrates, localisation, depth, fluorescein stain-
ing). The appearance of infiltrates was graded as no infiltrates visible (0), faint infiltrates 
(1), mild distinguished infiltrates (2), moderate, round distinguished infiltrates (3), se-
vere, not round distinguished infiltrates (4). Localisation of present infiltrates was graded 
as superior (0), in periphery (1), in midperiphery (2), central (3) and whole cornea af-
fected (4). Depth in which the infiltrates were present was graded as epithelial (1), 
subepithelial (2), anterior stroma (3) and associated substance loss of the cornea in ef-
fected area (4). Fluorecein staining over the present infiltrate was graded as no staining 
(0) negative (dark spots) staining (1), epithelial staining (2), delayed diffusion into stroma 
(3) and immediate diffusion into stroma (4). Finally present scars in corneal stroma was 
graded as none (0), diffuse scars smaller than 2mm (1), focal scars 2-4mm big (2), focal 
scars bigger than 4mm (3) and loss of cornea integrity (4).  
3.4.2 Conjunctiva 
The bulbar conjunctiva was divided into a limbal zone (1) and a bulbar zone (2) respec-
tively (Figure 2). 
 
Figure 2: Conjunctiva devided into limbal zone (1) vs. bulbar zone (2) 
Both zones were inspected for Hyperemia and Edema. For Hyperemia the grading was 
defined as no redness (0), slight focal Hyperemia (1), slight diffuse Hyperemia (2), mod-
erate local or diffuse Hyperemia (3) and severe circular Hyperemia (4) for the limbal 
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zone and severe episcleral or scleral Hyperemia (4) for the bulbar zone. Grading for 
Edema for both zones was defined as no Edema (0) and slight Edema without conjunc-
tiva folds (1). Grading (2) for the limbal zone was defined as severe local Edema, for the 
bulbar zone as several local Edema spots. Grading (3) was defined for limbal zone as 
slight circular Edema and for the bulbar zone as moderate general Edema. The highest 
Score (4) was given by severe circular Edema (Chemosis) for the limbal zone and for 
the bulbar zone for severe general Edema (Chemosis). 
The palpebral conjunctiva can be divided into five zones (Figure 3). Zone 1 nearest the 
palpebral border, zone 2 the central area, and zone 3 the area along the lid margin of 
the palpebral plate. Zone 4 the area near the nasal region and zone 5 the area near the 
temporal region. CLPC is classified as local if papillae are present in only one or two 
zones of the conjunctiva and general if papillae are scattered across more than two 
zones or over the entire conjunctiva.35 All of the five zones were assessed in the analy-
sis.  
 
Figure 3 Five zones of the upper palpebral conjunctiva (right eye shown) 
In examining the upper and lower palpebral conjunctiva, the size and location of the pa-
pillae, staining of the papillae and conjunctival hyperemia were noted and graded after 
the clinical grading scale developed by the CCLRU grading scales from zero to 4 in 
which 0.0 corresponds to no response, 1.0 corresponds to slight, 2.0 corresponds to 
mild, 3.0 corresponds to moderate, and 4.0 corresponds to severe response.101,102,103 
(Figure 4) 
Hyperemia and papillae of the upper and lower palpebral conjunctiva were graded using 
the CCLRU grading scales as well. Any grading exceeding grade 2 was considered 
clinical relevant. If papillae were 0.3 mm or greater in diameter, with increased hyper-
aemia, the condition was classified as CLPC.34,44 
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Figure 4: CCLRU Grading Scale 0 – 4 for the upper Lid Conjunctiva 
Clinical diagnosis of CLPC and FoCoSi was based on biomicroscopic findings of papil-
lary changes of the upper and lower palpebral conjunctiva. As FoCoSi classified were all 
subjects, which shown enlarged papillae that assumes a follicular-like appearance with 
the absence of the usual central vessel characteristic of papillae. An example of a Fo-
CoSi event is shown in Figure 5. Notice the numerous white spots with the absence of 
the central vascular tuft, whereas the surrounding papillae are present with a central 
vessel. This conjunctival changing’s can be seen using the slit lamp biomicroscope, 
however with Adobe Photoshop 7.0 software modified colour presentation, the FoCoSi 
differences can be observed much better. In Figure 5 the modified picture contains less 
red but more blue light. In detail the photoshop colour balance was changed as follows:  
• colour code value for medial tone and lights: cyan -100 
• colour code value for deep tone: red +14 
 
Figure 5: FoCoSi example as the original picture and as a software modified version 
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Grading for follicular-like papillae presented in the upper and lower lid was devided into 
several subdivisions. First of all, the quantity of present follicular-like papillae was 
graded as none (0), 1 to 5 spots (1), 6 to 10 spots (2), 11 to 20 spots (3) and more than 
20 spots (4). If at least 1 FoCoSi spot was present, fluorescein staining was evaluated 
and graded as no staining (0), 1 fluorescein positive spot (FPS) (1), 2 to 3 FPS (2), 4 to 
6 FPS (3) and more than 6 FPS (4). Additionally if at least 1 FoCoSi spot was present, 
the Hyperemia and Edema was graded for that area as none (0), slight Hyperemia and 
rough surface (1), slight Hyperemia with Edema (2), moderate Hyperemia with Edema 
and slight mucous discharge (3) and severe Hyperemia with Edema and heavy mucous 
discharge (4). Additionally the character of tear secretion was graded as normal (0), 
slight serous (1), serous discharge with slight mucous (2), moderate mucous discharge 
with some lid lashes sticking together (3) and severe mucous discharge with lid lashes 
sticking together (4). 
3.4.3 Contact lens examination 
In order to prescribe possible correlations on the appearance and frequency of FoCoSi, 
a variety of different contact lens parameters and wearing modalities were noted. Be-
sides the type of the used contact lens, additionally listed was the age of the contact 
lens, wearing modality, movement and appearance of any material defects were noted 
with specifically developed grading scales from zero to 4. The age of the contact lens 
was noted as discontinued lens wear in the last days (0), very first day (1), one third of 
planned replacement time (2), two third of planned replacement time (3) and right before 
replacement (4). Wearing modality was noted as discontinued lens wear in the last days 
(0), DW (1), flexible wear (FW) (2), maximum one week of EW (3) and continuous wear 
(CW) up to a maximium of one month, 1 week for Senoflicon A respectively (4). Vertical 
movement of the contact lens during normal blinking in main gaze was noted as more 
than 1.5mm (0), between 1.0mm and 1.5mm (1), between 0.5mm and 1.0mm (2), lover 
than 0.5mm (3) and no movement at all (4). Finally material defects were noted as no 
defects (0), slightly uneven edges (1), small tears at the edge (2), peaces of material 
lack on the edge (3) and central defects (4).  
The type and frequency of the used contact lens solutions was assessed with grading 
scales from zero to 4 as well, in which (0) corresponds to daily use, (1) corresponds to 
once in a week, (2) corresponds to once in 2 weeks, (3) corresponds to less than once 
in 2 weeks, and (4) corresponds to no use at all. Solutions were divided into no solution 
used (0), multipurpose biguanid (1), multipurpose polyquad (2), Peroxide Systems (3) 
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and manual cleaner or protein removing agent (4). As deposits on the surface of a con-
tact lens are an important factor in comfort of wearing contact lenses and can be a trig-
ger for CLPC, five different types of deposits (Lipid, Mucin, hydrophobic spots, cosmet-
ics and mixed deposits) were noted and graded. The Grading scale was again from 0 to 
4 in which (0) corresponds no deposits, (1) corresponds to slightly (1-2mm area), (2) 
corresponds to mild (3-4mm area), (3) corresponds to moderate (bigger than 5mm area) 
and (4) corresponds to severe (Vacc effected). 
3.5 Statistical Analyses 
Data from subjects that began EW or DW attended at least one scheduled EW or DW 
visit were included in this study. The first adverse response to contact lens wear during 
EW or DW was used to categorize the subject eyes into groups. Eyes that did not de-
velop any adverse response to contact lens wear during the follow-up period were retro-
spectively categorized as asymptomatic controls. The adverse response groups in-
cluded FoCoSi only. Clinical and subjective variables were collected at scheduled and 
unscheduled visits. Data for all events in the right or left eye or both eyes were recorded 
for clinical variables. All continuous variables were compared for differences among 
controls and the FoCoSi group using analysis of variance with mixed and random ef-
fects. Multiple comparisons were performed with Tukey HSD post hoc analysis. Cate-
gorical variables such as percentage of subjects reporting symptoms were compared 
between the groups using the chi-squared test and followed by Fisher exact test for mul-
tiple comparisons. Statistical significance was set at p≤0.05 for clinical variables. SPSS 
(Version 12) was used for all data analyses. 
4 Results 
4.1 General Results 
A total of 46 FoCoSi subjects were seen, which was an incidence of 3.8%. Subjects 
ranged in age from 19 to 63 years with a mean of 31.98 years of age and 56.5% of them 
were female (Table 6 + 7). Gender (p=0.058) and age (p=0.633) are not significant fac-
tors for the development of FoCoSi. For Gender there was a tendency for males to be 
more prone for developing FoCoSi than female subjects. 
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N 46 
Mean Score 31.98 
Median 31.0 
SD +/-  8.953 
Minimum 19 
Maximum 63 
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Table 6 Age distribution 
43.5%
56.5%
Male
Female
 Table 7 Gender distribution 
Seasonal differences in occurrence of FoCoSi events showed peaks in January, April 
and essentially during June until August (Table 8).  
 
Table 8 Seasonal Difference in occurrence of FoCoSi Events 
Allergies against Pollen were only associated in 50% of all subjects with FoCoSi. Of 
those subjects with Pollen allergies the season of allergy reaction was noted as during 
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Spring in 28.3%, during Summer in 10.9% and during the whole Pollen season from 
Spring to Summer 8.7%. Atopic reactions during the whole year had 2.2% of the sub-
jects prescribed. (Table 9) There was no correlation between reported allergy propensity 
and the seasonal distribution of FoCoSi events. (p=0.108) 
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Table 9 Allergy against Pollen 
Tearing was in great majority of the subjects with FoCoSi (80.4%) normal, pronounced 
tear meniscus was observed in 17.4% and rarely overflowing tears were noted in 2.2%. 
None of the subjects showed excessive tearing or epiphora. (Table 10)  
None of the subjects presented with FoCoSi showed pre-auricular lymphadenopathy. 
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Table 10: Tearflow in subjects with FoCoSi 
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53.3% reported no symptoms at all during the event of FoCoSi. Noticeable symptoms 
but without any limitations in contact lens wear was found in 15.2%, slight annoying 
symptoms with slightly limitations in contact lens wear in 13.0%, moderate symptoms 
and limitations in contact lens wear in 16.3% and finally severe symptoms with severe 
limitations in contact lens wear was reported in 2.2% of the subjects. (Table 11) 
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Table 11 Severity of Symptoms 
4.2 Results of slitlamp examination of Cornea and Conjunctiva 
4.2.1 Cornea 
No subject with FoCoSi showed stromal Edema, Microcysts or Vacuols. Only 1 subject 
presented staining, 2 subjects (2.2%) presented infiltrates respectively. The 2 subjects 
with Infiltration had subepithelial Infiltrates in the superior periphery and showed no posi-
tive fluorescein staining. The single staining subject presented 1-20 epithelial punctates 
in the inferior part of the cornea. Vascularisation was noted as no vascular penetration 
into the cornea in 72.8% of subjects with FoCoSi, 18.5% had vascularisation smaller 
than 1mm in 94.1% in a circular presentation, 5.9% showed that amount of vascularisa-
tion in the temporal part of the cornea. 8.7% had vascularisation between 1mm and 
2mm, 50% of them presented that amount of vascularisation circular and 25% superior, 
respectively inferior. Finally no scarring was present in 90.2% of subjects with FoCoSi. 
6.5% showed just small diffuse scarring, where 3.3% had focal scars between 2mm and 
4mm in size. The study wasn’t designed to distinguish if the results of the cornea section 
were persistent before FoCoSi occur, or if those findings were newly developed during a 
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FoCoSi event. The main reason in that study for the cornea section was to rule out any 
viral infection. 
4.2.2 Conjunctiva 
No subject with FoCoSi showed limbal hyperemia or limbal edema above the clinical 
relevant grading of 2. The bulbar conjunctiva showed no hyperemia over grade 2 as 
well. Only 1.1% showed a bulbar edema with grade 3 but none of the subjects had a 
grading above 3. None of the subjects over exceed grading 2 in the lower palpebral con-
junctiva for papillae. In the superior palpebral conjunctiva only 6.5% of the subjects 
showed no increased numbers and sizes of papillae. 43.5% had slight papillae with 
slight hyperemia, 34.8% showed mild hyperemia with papillae below 1mm size, 12.0% 
showed moderate papillae formation with a size between 1-3mm and moderate hy-
peremia and edema, whereas 3.3% showed severe papillae formation bigger than 3mm 
in size with severe hyperemia and edema of the palpebral conjunctiva. (Table 12) 
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Table 12: Papillae in the superior palpebral conjunctiva 
Follicular-like papillae were not found in the lower palpebral conjunctiva of any FoCoSi 
subject. The FoCoSi reaction was only found in the superior palpebral conjunctiva. 
Every appearance of FoCoSi was graded as a clinical significant finding, in contrast to 
the other findings which were graded as clinically significant above the grading 2. 22.8% 
of the subjects showed only monocular FoCoSi response. Observing the superior palpe-
bral conjunctiva for each eye separately, 33.7% showed 1-5, 26.1% showed 6-10, 
13.0% had 11-20 and 4.3% showed more than 20 FoCoSi spots. (Table 13)  
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Table 13: Numbers of follicular-like papillae formation in superior palpebral conjunctiva 
Classification into local and general form of appearance was performed as well. All sub-
jects presenting less than 11 follicular-like papillae formation were labelled as local, 
whereas the others labelled as general form of distribution. 83.6% were classified as 
local and only 16.4% of the subjects showed the general form of distribution. FoCoSi 
subjects with the general form reported significantly (p=0.003) more symptoms. Fluo-
rescein staining was performed for two reasons. With fluorescein staining the papillae 
itself are better visible and easier to grade and to reveal persisting FPS on the apex of 
some papillae, or better FoCoSi respectively. (Figure 6) Not all of the FoCoSi subjects 
showed FPS, 36.6% presented the whole superior conjunctiva as fluorescein negative. 
23.9% had 1 FPS, 22.5% had 1-3 fluorescein positive spots, 11.3% had 4-6 FPS and 
5.6% had more than 6 FPS.  
 
Figure 6: FoCoSi of one eye presented on a slitlamp under normal light and with fluorescein staining 
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14.1% of subjects with FoCoSi were graded with no Hyperemia and Edema of the supe-
rior conjunctiva, 35.2% showed slight Hyperemia and a rough surface, 22.5% showed 
slight Hyperemia with Edema, 23.9% moderate Hyperemia with Edema and slight mu-
cous discharge and 4.2% showed severe Hyperemia with Edema and heavy mucous 
discharge. Observing the correlation between the amount of FoCoSi spots found and 
the amount of FPS showed that for the group with more than 20 FoCoSi spots noted, 
the highest amount of FPS was noted as well. This finding was statistically significant 
(p=0.020). (Table 14) The similar result was found for Edema, in order that the Edema 
was more severe in the group with more than 20 FoCoSi spots. This finding was statisti-
cally significant as well (p=0.015). (Table 15) Additionally the correlation between the 
reported subjective symptoms and objective findings of FoCoSi in the meaning of the 
amount of FoCoSi spots, the edema and the amount FPS in the superior palpebral con-
junctiva was calculated. Interestingly all three parameters presented similar results. 
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Table 14: Correlation between the amount of FoCoSi and FPS 
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Table 15: Correlation between the amount of FoCoSi and Edema 
If the objective findings of FoCoSi were worth, the reported symptoms were worth as 
well. In detail, if the edema was graded worth, the symptoms were graded worth as well. 
That finding was strongly significant (p=0.002). (Table 16) For the amount of FoCoSi 
spots in general the same statistically significant correlation was found as it was for 
edema findings (p=0.003). (Table 17) Finally the more FPS were observed in superior 
palpebral conjunctiva, the more severe subjective symptoms were prescribed. Statisti-
cally showed that correlation the weakest significance (p=0.032) from the observed 
three findings. In comparing subjects without FPS reaction and those with more than 6 
spots, there was a strong statistically correlation (p=0.001) indicating that a higher FPS 
grading results in more severe symptoms. (Table 18) 
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Table 16: Correlation between Symptoms and Edema in the superior palpebral conjunctiva 
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Table 17: Correlation between symptoms and the amount of FoCoSi in the superior palpebral conjunctiva 
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Table 18: Correlation between symptoms and FPS in superior palpebral conjunctiva 
Finally 57.6% of subjects had normal tear secretion, 17.4% had slight serous tears, 
13.0% had serous discharge with slight mucous, 9.8% had moderate mucous discharge 
with some lid lashes sticking together and 2.2% had severe mucous discharge with lid 
lashes sticking together. There was a statistically significant correlation between the 
character of the noted discharge and the conjunctival edema and FPS respectively 
(p<0.050). If the subjects had severe edema or a higher amount of FPS, the discharge 
was more severe and more mucous like. (Table 19 and Table 20) 
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Table 19: Correlation between discharge and FPS 
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Table 20: Correlation between discharge and conjunctival edema 
4.3 Results of the contact lens section 
The contact lens types most often involved in FoCoSi were Senofilcon A (45.7%), 
Lotrafilcon A (26.1%), Balafilcon A (19.6%), Galyfilcon A (8.7%) and none of the sub-
jects presenting FoCoSi used Lotrafilcon B. Due to the small number in the cohort, 
Lotrafilcon B was not considered for statistical evaluation. (Table 21) These results were 
statistically significant (p=0.005) in compare with the asymptomatic control group. To be 
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clearly evident, the risk-ratio for developing FoCoSi for each contact lens material used 
was calculated and can be seen in Table 22.  
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Table 21: Contact lens type showed FoCoSi 
Lotrafilcon A (2.49) and Senofilcon A (1.53) showed the highest risk ratio, followed by 
Balafilcon A (0.70) and Galyfilcon A (0.29). 
 
Table 22: Risk-Ratio for developing FoCoSi, for the different contact lens materials 
 
The contact lenses were worn in different modalities. 56.5% used their contact lenses 
on CW basis, up to 1 month as a maximum, except 1 week for Senofilcon A material 
respectively. 26.1% used their contact lenses DW only, whereas 15.2% slept in their 
contact lenses 1 time in a week on a regular basis (EW). Finally 2.2% of subjects slept 
with their contact lenses sometimes, (FW) but usually not. (Table 23)  
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Table 23: Wearing modality 
Wearing modality and contact lens material did not differ significantly (p=0.338). In the 
DW group 41.7% used Senofilcon A, 25.0% used Balafilcon A and finally Lotrafilcon A 
and Galyfilcon A contact lens material was used in each 16.7%. 50% of FW and EW 
subjects used Senofilcon A, whereas each 4.3% used Balafilcon A and Lotrafilcon A 
respectively. Finally in the CW group 46.2% used Senofilcon A, 30.8% used Lotrafilcon 
A, 15.4% used Balafilcon A and 7.7% used Galyfilcon A (Table 24). 
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Table 24: Wearing modality and used contact lens material 
The life span of each contact lens worn, at the time of FoCoSi happened, was reported. 
40.2% of the contact lenses were on their end of life span, whereas 33.7% were in first 
third of their life span. 21.7% were in second third of life span and each 2.2% of subjects 
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had the contact lens the first day on the eye or discontinued wearing their contact 
lenses. (Table 25)  
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Table 25: Life span of worn contact lenses 
Only 2 contact lenses had small tears on the edge (2.2%), all the other contact lenses 
showed no material defects at all. The great majority (91.3%) of contact lenses showed 
movement of 0.5mm to 1.0mm (80.4%) or lower than 0.5mm (10.9%). 5.4% showed 
movement up to 1.5mm and 3.3% showed movement above 1.5mm. 
4.3.1 Solution Analysis 
79.3% of all FoCoSi subjects used a Polyquad preserved multipurpose solution (MPS), 
10.9% used no lens care solution at all, all of those subjects wearing modality was CW. 
6.5% used Peroxide and 1.1% used an additional manually cleaning system (Table 25). 
Polyquad was used by 75% of subjects which used their contact lenses DW, whereas 
16.7% of them used Peroxide and 8.3% used a Biguanid preserved MPS. Subjects 
wearing FW or EW modality, 87.5% used Polyquad MPS and 12.5% respectively used 
Peroxide as their lens care solution. Of the CW subjects again the great majority used 
Polyquad MPS (78.9%) but was only used for special disinfecting purpose, for example 
after swimming or long flights, 19.2% had no lens care solution at all, whereas one sub-
ject (1.9%) used an additional manual cleaner during the period of FoCoSi. None of 
those CW subjects used Biguanid MPS. None of the correlations found above were sta-
tistically significant (p=0.494) (Table 27).  
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Table 26: Solution Type, independent of wearing modus 
Additionally the frequency of solution application during the FoCoSi event was reported 
as well. 41.3% of FoCoSi subjects never used lens care solution, 28.3% used their solu-
tion everyday, 21.7% once in a week, 6.5% less than once in 2 weeks and 2.2% used 
their solution once in 2 weeks. (Table 28) Comparing this data with the contact lens ma-
terial showed that for the Balafilcon A group each third used the solution daily, once in a 
week and less than once in 2 weeks or never. For the Lotrafilcon A group; 50% never 
used a solution, 33.3% used the solution once in a week and 16.7% everyday. In the 
Galyfilcon A group 50% used the solution everyday and the other 50% never. Finally in 
the Senofilcon A group 52.4% never used a solution or less than once in 2 weeks, 
28.6% used it everyday, 14.3% once in a week and 2.2% used it just once in 2 weeks. 
(Table 29) There was no correlation between used contact lens material and application 
frequency of the solution. (p=0.592) 
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Table 27: Solution Type, dependent of wearing modus 
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Table 28: Application frequency of solution 
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Table 29: Contact lens material and solution application frequency 
4.3.2 Deposits 
The degree of deposits and type of material deposited on the surface was reported for 
each subject. Lipids are a common deposition for SH. In this study 22.8% did not have 
any visible Lipid deposits, 44.6% had slight lipid deposition, 20.7% had mild deposition 
and 12.0% had moderate deposition. Interestingly no subject had severe lipid deposi-
tion. While mucin is heavily produced in CLPC, deposition of mucin material would be 
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logical. But 76.7% of subjects showed no mucin deposits at all, 13.3% showed slight 
deposition, 7.8% had mild and 2.2% moderate mucin deposition. Again none of the sub-
jects showed severe deposition. Hydrophobic spots where rarely observed. 90.2% had 
no spots at all, 3.3% slight dry spots and 6.5% had mild hydrophobic spots. None of the 
subjects had moderate or severe hydrophobic areas. A surprisingly high amount 
(89.1%) of the subjects had no deposits of cosmetic products. 6.5% had slight, 3.3% 
mild and 1.1% severe cosmetic depositions. None of the subjects had moderate cos-
metic deposition. There was no statistically significant correlation between the severity 
of conjunctival edema, nor FPS in the superior palpebral conjunctiva and the amount of 
the previous discussed specific depositions on the contact lens surface (p>0.050). 
Finally the amount of mixed depositions was noted. 57.6% showed no deposition at all, 
19.6% slight, 12.0% mild, 5.4% moderate and 5.4% severe mixed depositions. Subjects 
with more severe follicle-like papillae formations (Edema p=0.021, Staining p=0.008 and 
FPS p=0.032) where observed with significantly more mixed deposition. (Table 30 and 
Table 31) 
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Table 30: Correlation between mixed deposition and FPS 
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Table 31: Correlation between mixed deposition and conjunctival edema 
Comparing the different contact lens materials and the type of deposition noted, there 
were no significantly differences found for the different depositions, except for lipid. 
Balafilcon A material does attract statistically significantly more lipids (p=0.012) than the 
other materials. (Table 32) 
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Table 32: Comparing lipid deposition and contact lens materials 
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5 Conclusion and Discussion 
This study confirms the clinical presentation of follicular-like conjunctivitis associated 
with Siliconhydrogels (FoCoSi) in cases with CLPC.  
5.1 Aetiology 
The incidence was with 3.8% quite lower than reported in events with CLPC13-21. Gender 
and age were not a significant factor in developing FoCoSi which correlates to CLPC.11 
Whitish appearance in severe CLPC or GPC cases with a longer period of time was 
presumed to be a cicatrisation of the conjunctiva surface at the apex of the papillae and 
appear in a cream/white colour.24,96 The onset time for FoCoSi after the first introduction 
to SH contact lenses, was between 4 month and 8 years. This indicates that it is not a 
matter of time or a chronical pathway that FoCoSi occur. To the contrary it seems to be 
an acute reaction. Sugar et al44 presumed a thickening of the overlaying conjunctiva as 
the reason for a milky appearance in some cases of GPC after keratoplasty. In earlier 
stages the papillae apex can display infiltrates, which appear in a whitish colour as well. 
These observings matches better to the appearance of FoCoSi than a cicatrisation of 
the conjunctiva. If the immunohistochemical studies for CLPC33-39 represent the same 
findings in subjects with FoCoSi, infiltration of inflammatory leucocytes could give an 
explanation of the whitish appearance of FoCoSi. Sulfidopeptide LK increasing mi-
crovascular permeability,86  which has the potential for creating an edema in the sur-
rounding conjunctiva leading in the characteristic shape of FoCoSi. 
5.1.1 Environmental influence 
An interesting finding was the seasonal distribution of FoCoSi events with peaks in 
January, April and during summer until August. Even if studies have shown that patients 
with a history of allergy seem to be more susceptible to CLPC,20,53-54 our findings did not 
proper correlate with allergies to pollen reported by the subjects. 50% of all FoCoSi sub-
jects did not report any known allergy at all. Especially the January reports, during win-
ter, can’t be explained with pollen counting. Other factors like high pollution of the air 
could give an answer to that question. During the winter season, long period of atmos-
pheric inversion condition are common in Switzerland.104 While the lower parts of Swit-
zerland are predominantly covered by fog, the higher areas enjoy longer period of sunny 
days. During that condition temperature in the lower parts are cooler than in the higher 
alpine regions, resulting in minimal air exchange between both layers and the pollution 
of the air rises dramatically. Other meteorological factors such as Ozone (O3) and Tem-
perature could have an impact on FoCoSi development as well. During April until August 
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2007 O3 frequently over exceed the limit value (120 µg/m3) published by swiss federal 
emission control.105 Pollution characterized by elevation of oxides of nitrogen (NOx), O3, 
tobacco smoke, fine and ultra fine particulate and diesel exhaust particles seems to en-
hance allergic disease.106 Additionally the bioavailability of grass pollen allergens may be 
modulated by air pollutants. Interestingly, cleaning those pollen from air pollutants, re-
duces the allergic reaction significantly.107 We have further studies arranged to clear up 
these questions. 
5.1.2 Unilateral vs. bilateral presentation 
CLPC was reported only in 10% of the cases as a truly monocular event,17 whereas a 
study with data’s from Australia and India21 showed with 78.4% the highest amount of 
unilateral CLPC events reported so far in a study. In our cohort 22.8% of FoCoSi events 
were unilateral. This phenomenon can’t be explained with unilateral different mechanical 
irritation as it clearly is in the prescribed GPC cases with foreign bodies on the ocular 
surface.37-42 All of the FoCoSi subjects have worn the same contact lens material on both 
eyes and only two lenses had minor material defects, which could have introduced uni-
lateral mechanical irritation to the tarsal conjunctiva.  
On the other hand immunological responses were discussed as a reason for CLPC,33-
35,38,55,84-85
 the fact that there were a great number of unilateral FoCoSi events may indi-
cate that factors other than general immunologic responses may contribute to the 
pathogenesis of FoCoSi condition. Additionally ocular viral infections are often unilateral 
in the beginning, but with all the negative corneal and conjunctival findings related to 
viral infections and negative pre-auricular lymphadenopathy as well, viral involvement 
can be ruled out. We did not find a rational explanation for those unilateral findings so 
far. Further studies should be done on that topic. 
5.1.3 Local vs. general form 
As prescribed in Australia there are local (81.8%) and general (18.2%) presentations of 
CLPC.21 FoCoSi showed a similar distribution (83.6% local vs. 16.4% general). In very 
close agreement with CLPC,21 FoCoSi subjects with the general form reported signifi-
cantly (p=0.003) more symptoms. However, the mechanisms of action and aetiology of 
local vs. general CLPC are poorly understood and clinical variables such as physiologic 
parameters of limbal and bulbar redness, lens surface and lens-fitting parameters could 
not differentiate between the subjects who developed either local or general CLPC.21 For 
FoCoSi no correlation between local or general form and contact lens material, wearing 
modality, lifespan of contact lens, movement of contact lens, corneal reaction nor limbal 
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and bulbar redness could be found as well. In summary none of the included parame-
ters of our study design showed an explanation for the different distribution of local and 
general FoCoSi form. 
5.1.4 Fluorescein positive spots (FPS) 
In the FoCoSi study, FPS appeared as the most relevant objective clinical parameter. 
Those subjects presenting FPS had more severe symptoms, mucus discharge and so 
for coated contact lenses. These spots were always observed on the apices of follicular-
like papillae. In contrast there was no FPS in normal papillae formation. Due to FPS, the 
FoCoSi syndrome can be divided into an active and a dormant stage of presentation. 
The active form only, with FPS, was responsible for the subjective symptoms patients 
noted, whereas the dormant form, without FPS, was only detected through previously 
prescribed objective findings. Interestingly, the dormant form was only observed in pa-
tients previously presented an active form once in their lifetime. 
FPS or whitish areas in CLPC or GPC have been discussed in only few studies so far. 
24,39,44,108
 Fluorescein staining occurs with epithelial cell damage and frequently occurs 
with papillae with apices that are flattened or crater-like. The reason for those alterations 
was presumed to be the initiating mechanical trauma.24,39,94 Greiner41 in contrast found no 
FPS over those whitish papillae in GPC due to an epithelialized foreign body. Lotrafilcon 
A with the highest modulus (1.4) of the studied materials give support to that presump-
tion. But mechanical trauma alone, as reason for FoCoSi and FPS seems to be unlikely, 
since Senofilcon A material with a very low modulus (0.6) had the second highest inci-
dence of FoCoSi events. Additionally Senoflicon A contact lenses showed the lowest 
amount of movement on the bulbar conjunctiva, which should have a positive effect from 
the mechanical point of view. Finally there were in the majority no defects on contact 
lens edge designs found, which could have induced FoCoSi or staining.  
Another approach is to recognize FPS as a consequence of an inflammation or immu-
nological process rather than the cause for FoCoSi. The immunohistochemical studies 
for CLPC33-39 not only gives an explanation of the whitish appearance of FoCoSi caused 
by inflammatory leucocytes infiltration, further more it gives an explanation for FPS as 
well. Those processes promoting better infiltration of leucocytes can enhance the per-
meability of the overlying epithelium as well, resulting in possible staining with fluo-
rescein.  
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5.2 Contact lens influence 
Subjects wearing Lotrafilcon A (2.49) and Senofilcon A (1.53) contact lenses reyspec-
tively had the highest risk-ratio for developing FoCoSi. Especially if the contact lenses 
were worn on a CW basis.  
5.2.1 Deposition on contact lens surface 
FoCoSi events may be indicative of an immunologic response to deposits that accumu-
late on the contact lens surface as it was reported for CLPC in several studies.17,53-54,59,61-
63,83
 It is believed that these deposits or the exposure of the upper lid to allergens, espe-
cially denatured protein,53 on the contact lens surface is the initiating factor and subse-
quent immunologic reaction that occurs in CLPC. In the present study, if FoCoSi gets 
worth, edema and the numbers of FoCoSi and especially the amount of FPS, the 
amount of mixed deposition on the contact lens surface was increased as well. But that 
presents more the consequence of the increased mucus discharge rather than the 
cause. A shorter replacement schedule of contact lenses was discussed in former stud-
ies to be preferable to avoid CLPC,13-14,19 especially 1 week replacement cycle showed 
no CLPC formation at all.20 These findings make sense in order to prevent the ocular 
environment from getting in contact with high amount of denatured protein depositions. 
However, 20.1% of FoCoSi events were found in patients wearing their contact lens 1 
week CW (53.9% of subjects in the CW group: 46.2% Senoflicon A and 7.7% Galyfilcon 
A). This finding suggests that, other deposition or mechanism hypotised for CLPC so 
far, may play a role in the aetiology of FoCoSi, if any. On the other hand the older the 
life span of the contact lenses the more prone the subjects were for FoCoSi. This indi-
cates that there is a certain time of interaction between the eye and the contact lens 
needed, before FoCoSi occur. 
SH materials have different deposition profiles to that seen with conventional hydrogel 
lenses and can be summarized as less accumulative to protein but with a higher per-
centage of denatured protein61-62 and with a significant higher affinity to lipids.72-77 Lipid 
depositions are progressive, cumulative and does not plateau like protein. Because of 
great intersubject variability in lipid deposition it was suggested that protein deposition is 
driven primarily by contact lens material, whereas lipid deposition is related to both ma-
terial composition and intersubject differences in tear film components, blink factors and 
environmental factors.70 In the present study the deposition profiles were equal between 
the different contact lens materials. Only the amount of lipids was greater in Balafilcon A 
than for the other materials, but in contrast this material showed only a low incidence for 
FoCoSi. There must be said, that the amount of deposition was only judged by using slit 
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lamp impression. Subjects with more severe follicle-like papillae formations (Edema 
p=0.021, Staining p=0.008 and FPS p=0.032) where observed with significantly more 
mixed deposition, but this indicates more the result rather than the cause of FoCoSi. 
Especially in subjects with FPS a severe mucus discharge was frequently observed. 
Concentrating on Lotrafilcon A and Senofilcon A with the highest incidence of FoCoSi, in 
former studies Lotraficon A showed the highest amount for denaturated Protein and 
Senofilcon A the lowest.76 For lipids Senofilcon A showed the highest and Lotrafilcon A 
the lowest amount.70,77 Additionally the two materials are extremely different over a great 
variety of parameters, for example modulus or coating. These findings indicate that 
there is not an easy explanation of how FoCoSi occur. One may suggest, that denatured 
protein depositions alone are not responsible for FoCoSi, lipid depositions must be con-
sidered as well. Even though, lipids alone do not appear to be antigenic77 they can be 
transformed or influenced for example with O3. These are new ideas to clear up the 
questions of aetiology of FoCoSi and perhaps giving a new approach for solving the 
questions around CLPC as well. Further studies should be done on that topic. 
5.2.2 Care Solution 
The most related contact lens care solution with FoCoSi was Optifree express® (Alcon). 
In compare with the control group, this finding was not statistically significant (p>0.05), it 
is the predominant solution used in that group as well. Furthermore, while looking at the 
high amount of CW subjects, which did not use any care solution at all, it seems that the 
care solution plays a minor role in FoCoSi development and the follicular-like changing’s 
are not a reaction to certain solution components. 
5.3 Treatment of FoCoSi 
The study design wasn’t specificly made for evaluating the treatment of FoCoSi. How-
ever, two major treatments, changing wearing modality to DW or wearing daily dispos-
able contact lenses for a 2 week to 4 week period of time, seems to be successful in 
solving the subjective symptoms during FoCoSi. If the subject was in CW, reducing 
wearing modality to DW was mostly effective enough. If the subject already was in DW, 
discontinuation of contact lens wear or changing to a daily disposable contact lens was 
successful. All FoCoSi subjects were able to resolve the syndrome and could continue 
with contact lens wear after treatment. On the other hand, with that treatment only FPS 
and edema was completely solved. The FoCoSi spots itself remain with a follicular-like 
whitish appearance as prescribed as the dormant form of FoCoSi without any subjective 
complains. 
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Due to the juridical situation in Switzerland we were not allowed to use medications for 
treatment. Further studies on that topic should be done to figure out which, if any, medi-
cation could bring the dormant FoCoSi back to normal palpebral conjunctival appear-
ance. 
5.4 Summary 
FoCoSi is a novel and relevant subtype of CLPC. The aetiology seems to be unclear to 
date and raises new questions about the aetiology of CLPC as well. The theory of a 
combination of mechanical irritation and immunological hypersensitivity reaction is ques-
tionable, since the mechanical irritation of Senofilcon A can be classified as very low. On 
the other hand, lipid deposition on contact lenses rather than protein deposition and air 
pollution like O3 and fine and ultrafine particles are a new approach in finding the cause 
for FoCoSi or CLPC. Fluorescein staining of the apices has shown the highest correla-
tion with subjective symptoms. This is a new and clinically interesting knowledge as 
well. Finally the different presentation of FoCoSi like focal vs. general or bilateral vs uni-
lateral correlates very well to the reported findings in CLPC but our study design could 
not give an explanation for the aetiology of those findings. For clearing up all those new 
questions further studies should be performed.  
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7 Appendix 
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7.2 Grading Sheet 
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7.3 Observation Sheet 
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7.4 Collected Raw Data 
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